|4Jun 28, 8:31 PM ET

GRIFFITH MELINDA 4

4 · OncoCyte Corp · Filed Jun 28, 2021

Insider Transaction Report

Form 4
Period: 2021-06-24
Transactions
  • Award

    Option to Purchase Common Stock

    2021-06-24+45,00045,000 total
    Exercise: $5.46Exp: 2031-06-23Common Stock (45,000 underlying)
  • Award

    Restricted Stock Units

    2021-06-24+10,00010,000 total
    Exercise: $0.00From: 2022-06-24Exp: 2022-06-24Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
  • [F2]The Restricted Stock Units shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.

Documents

1 file
  • 4
    ownership.xmlPrimary